Division of Hematology/Oncology

Park Ridge, Illinois 60068

0 studies enrolling now · 7 studies all time

What they study most

Bladder Cancer, Colorectal Cancer, Lung Cancer, Malignant Mesothelioma, Prostate Cancer, Sarcoma, Transitional Cell Cancer of the Renal Pelvis and Ureter

Studies at this site

• Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer — Completed
• Oxaliplatin in Treating Patients With Metastatic Bladder Cancer — Completed
• O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma — Completed
• SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy — Completed
• SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer — Stopped early
• SU5416 in Treating Patients With Malignant Mesothelioma — Completed
• Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer — Completed